SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-000337
Filing Date
2018-01-09
Accepted
2018-01-09 07:00:38
Documents
22
Period of Report
2018-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 23156
2 ex99-1.htm EX-99.1 15918
3 image_001.jpg GRAPHIC 57259
4 image_002.jpg GRAPHIC 282749
5 image_003.jpg GRAPHIC 155254
6 image_004.jpg GRAPHIC 51616
7 image_005.jpg GRAPHIC 103485
8 image_006.jpg GRAPHIC 139452
9 image_007.jpg GRAPHIC 142831
10 image_008.jpg GRAPHIC 163462
11 image_009.jpg GRAPHIC 59183
12 image_010.jpg GRAPHIC 129317
13 image_011.jpg GRAPHIC 161223
14 image_012.jpg GRAPHIC 129187
15 image_013.jpg GRAPHIC 43987
16 image_014.jpg GRAPHIC 81946
17 image_015.jpg GRAPHIC 108813
18 image_016.jpg GRAPHIC 49828
19 image_017.jpg GRAPHIC 217307
20 image_018.jpg GRAPHIC 90438
21 image_019.jpg GRAPHIC 240901
22 image_020.jpg GRAPHIC 71362
  Complete submission text file 0001493152-18-000337.txt   3457305
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 18517841
SIC: 2834 Pharmaceutical Preparations